Christopher R. Flowers, MD | Authors


Pursuing Optimal Therapy Remains a Challenge in Indolent B-Cell Lymphoma

October 25, 2021

A significant proportion of patients worldwide live disease-free for a decade or longer following first-line therapy, with various approaches suggesting that there may be pathways to develop approaches for a cure for at least a subset of patients